BLAME/SLAMF8 Antibody (250014) [Biotin]
Novus Biologicals, part of Bio-Techne | Catalog # FAB19072B
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
CyTOF-ready, Flow Cytometry
Label
Biotin
Antibody Source
Monoclonal Mouse IgG1 Clone # 250014
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Mouse myeloma cell line NS0-derived recombinant human BLAME/SLAMF8
Ala23-Asp233
Accession # Q9P0V8
Ala23-Asp233
Accession # Q9P0V8
Specificity
Detects human BLAME/SLAMF8 in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant human (rh) SLAMF7 or rhSLAMF6 is observed.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for BLAME/SLAMF8 Antibody (250014) [Biotin]
Application
Recommended Usage
CyTOF-ready
Optimal dilutions of this antibody should be experimentally determined.
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified from hybridoma culture supernatant
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: BLAME/SLAMF8
Long Name
SLAM Family Member 8
Alternate Names
CD353, SBBI42, SLAMF8
Gene Symbol
SLAMF8
Additional BLAME/SLAMF8 Products
Product Documents for BLAME/SLAMF8 Antibody (250014) [Biotin]
Product Specific Notices for BLAME/SLAMF8 Antibody (250014) [Biotin]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...